Financials

  • Market Capitalization 1.5 B
  • Employee 975
  • Founded 2007
  • CEO N/A
  • Website www.iovance.com
  • Headquarter Delaware, United States
  • FIGI BBG000FTLBV7
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.5
Rapporto prezzo/fatturato
0

Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

Notizie